A Comparative Analysis of Prognostic Factors for Functional Outcomes in Patients With Acute Subdural Hematoma

Launched by CHARLES UNIVERSITY, CZECH REPUBLIC · Apr 8, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how well different scoring systems can predict recovery outcomes for patients with acute subdural hematoma (ASDH), a type of brain injury that often requires surgery. The researchers want to understand how age affects these predictions, as knowing the potential for recovery can help doctors make better treatment decisions.

To be eligible for the trial, participants must have undergone surgery for ASDH and be willing to be followed for 12 months to assess their recovery using a tool called the Glasgow Outcome Scale Extended (GOSE), which measures how well patients are doing after their injury. There are no specific exclusions, meaning most patients who meet these criteria can join. If you or a loved one is considering participation, you can expect to be part of a study that aims to improve understanding of recovery from this serious condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • surgery due to ASDH
• • 12 months of follow-up
• • functional outcome measured by the Glasgow Outcome Scale Extended (GOSE).
• Exclusion Criteria:
• • none